HANOVER, Md. and LEXINGTON, Mass. (PRWEB)
May 06, 2020

Sickle Cell Disease Association of America, Inc. (SCDAA) and Hemanext Inc., a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of red blood cell (RBC) transfusion therapy, are proud to announce a new partnership that will help SCDAA deliver on its mission and meet its goals. In 2020 Hemanext will collaborate with SCDAA on its educational programs, grassroots events and public-awareness campaigns.

Sickle cell disease (SCD) affects 100,000 individuals in the United States, disproportionately affecting African Americans with one in 500 African Americans suffering from the disease. People with SCD often require regular blood transfusions, particularly units of RBCs. Hemanext is committed to developing a novel RBC product to deliver improved and longer-lasting transfusions.

The genetic disease can cause unrelenting pain, stroke and acute chest syndrome (ACS), which is a collection of symptoms that include chest pain, cough, fever and other health concerns. Acute pain and vaso-occlusive crises (VOCs) are the top causes for hospitalizations and Emergency Department presentations, respectively, for sickle cell disease patients. Due to ACS, compromised immune systems and other medical problems, SCD patients are especially at risk during the coronavirus pandemic.

“During these very difficult times in the midst of the COVID-19 crisis, we appreciate and look forward to partnering with Hemanext to improve the lives of people with sickle cell disease and their families,” said SCDAA President and CEO Beverley Francis-Gibson. “We believe it is critical to partner with stakeholder groups like Hemanext to help garner support for such critical areas as research, public health education and patient services.”

“While much has been accomplished on behalf of sickle cell disease patients, we understand that more work remains in order to fully serve people living with SCD. As we continue to develop a better red blood cell replacement therapy to improve transfusions, we also are eager to partner with SCDAA, the premier sickle cell organization,” said Alex Marichal, VP, Marketing, Hemanext. “We appreciate the opportunity to help SCDAA achieve its mission and enhance the lives of members of the sickle cell community.”

The blood types needed for sickle cell patients are rare with the potential of less than 1% of the blood supply being a match for a patient. Therefore, preserving the nation’s blood supply is critically important to SCD patients and society at large. The U.S. blood supply is extraordinarily sensitive to situational disruptions, from fewer people donating blood during the summer and December holiday seasons to unanticipated events, such as fears that the coronavirus could make donors vulnerable to infection.

“The volatility of the blood supply cannot be resolved solely at the donor level; it requires innovation at the processing and storage levels,” said Hemanext President and CEO Martin Cannon. “We are developing a technology that can buttress the blood supply so that it is better able to withstand external volatility while also delivering a higher-quality, more uniform blood product. Our vision of a world with fewer and better transfusions is aligned with the SCDAA’s goals. It is a privilege to partner with the association on behalf of people living with sickle cell disease.”

About SCD

SCD, an inherited blood disease, causes red blood cells to have a sickle shape. Because of their stiffness and unusual form, blood flow is blocked to different tissues, ultimately damaging them. These sickle-shaped red blood cells contain an abnormal type of hemoglobin, hemoglobin S; normal red blood cells have hemoglobin A. Hemoglobin is important because it helps carry oxygen throughout the body. There is currently no universal cure for SCD.

About SCDAA

SCDAA’s mission is: To advocate for people affected by sickle cell conditions and empower community- based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure. Visit http://www.sicklecelldisease.org.

ABOUT HEMANEXT

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of transfusion therapy. The company’s research and development efforts center on the study and future commercialization of hypoxically stored red blood cells (RBCs). HEMANEXT ONE®, our initial product offering, is a RBC replacement therapy designed to potentially improve the quality of life for chronic and high-volume transfusion patients while reducing costs. Visit Hemanext.com to learn more.

The Hemanext RBC Processing System has not been cleared or approved by any regulatory agency (including the FDA), or any notified body, and is not available for sale.

SCDAA Media Contact:

Jackie Burrell

Director of Communications

jburrell@sicklecelldisease.org

Hemanext Media Contact:

Alex Marichal

Vice President Marketing

Alex.Marichal@hemanext.com

Share article on social media or email:

SACO, Maine (PRWEB)
May 06, 2020

CoWorx Staffing Services is looking to fill 1,000 Production Associate positions in Scarborough, Maine. First and 3rd shift positions are immediately available.

Newly hired employees will be working on the assembly of diagnostic test kits. These are entry level production positions, requiring a high school diploma or general education degree (GED), or equivalent combination of experience and education, and English-speaking proficiency.

Interested persons may apply directly at https://www.coworxstaffing.com/nowhiring/ or contact CoWorx Staffing Services at (207) 283-0082 for more information. Video interviews will be conducted where possible to limit office traffic and follow social distancing best practices.

About CoWorx

For 45 years, CoWorx Staffing Services has been helping job seekers grow their careers and employers build their workforce. CoWorx places candidates nationwide in administrative, light industrial, call center, and distribution and 3rd-party logistics positions, with an additional luxury beauty and fragrance division. Dedicated to workplace safety and with an ongoing commitment to diversity and partnership, CoWorx consistently earns Safety Standard of Excellence marks from the ASA and ranks among the largest staffing firms in the U.S., boasting more than 80 offices and 60,000 field employees nationally. The CoWorx philosophy, “Together we’re better,” embodies the company’s commitment to working collaboratively with clients, internal staff and field employees. To learn more about CoWorx, visit http://www.coworxstaffing.com.

Share article on social media or email:

Nurses at Abrazo Arrowhead Hospital in Arizona pose with Reshoevn8r’s signature shoe cleaning kits

We as a brand wanted to make sure the professionals that are diligently working to save lives feel especially important on a day that is set aside to honor their profession.

PHOENIX (PRWEB)
May 06, 2020

This year, National Nurses Day has even more meaning amidst the current global pandemic. Compelled to join the efforts in fighting the coronavirus — premium shoe care company Reshoevn8r is celebrating and honoring nurses by donating their signature cleaning kits to hospitals across the country. The brand, which relaunched earlier this year, not only wanted to honor healthcare professionals but also contribute in a way that would help the fight against COVID-19.

As research on the coronavirus is constantly being developed, it’s important now more than ever to defend against the virus in any way possible. And with information changing daily, new studies suggest that taking protective measures to clean your shoes will have a positive impact.

Researchers at the Huoshenshan Hospital in Wuhan wrote that half the samples from the soles of the shoes worn by ICU medical staffers tested positive for coronavirus and believe the soles may be acting as carriers of the virus.

New CDC (Centers for Disease Control and Prevention) research suggests that the best action to take in eliminating this bacteria is machine washing your shoes. Reshoevn8r’s state-of-the-art patented laundry system is designed specifically to clean shoes, and its sneaker laundry pods and bags allow for a seamless process to clean and condition your shoes in the washing machine.

Nurses at Dignity Health Los Angeles, New York Presbyterian Queens Hospital, Abrazo Arrowhead Hospital Phoenix and The University of Chicago Medical Center will receive Reshoevn8r’s Essential Cleaning Kit with hopes that it will show the brand’s appreciation for their hard work and deem absolutely useful in their everyday lives.

National Nurses Day hits home for Reshoevn8r’s Marketing Manager Jenesis Laforcarde, as her aunt puts her life on the line day in and day out as she serves as a nurse at Abrazo Arrowhead Hospital. “We as a brand wanted to make sure the professionals that are diligently working to save lives feel especially important on a day that is set aside to honor their profession.”

Reshoevn8r has cleaning solutions, spray repellent and portable sneaker wipes that can help in the process of eliminating bacteria. Reshoevn8r’s repellent spray adds a layer of protection to your shoes prior to going out, and the sneaker wipes are convenient for certain professions to have a quick cleaning solution on the go.

While the disease is more likely to be spread among medical workers, it’s safe for everyone to take protective cleaning measures after being in public — especially in places where the virus is more likely to spread. By everyone taking these extra precautions, we can help in decreasing the amount of contamination.

About Reshoevn8r

Reshoevn8r was founded in 2011 and has sold over 1,000,000 units, making the company one of the top premium shoe care brands in the world. Reshoevn8r is 100% all-natural, made with non-toxic ingredients like coconut, jojoba, and other natural oils. Reshoevn8r can be purchased directly on its website and retailers that sell the products include Urban Outfitters, Nohble, Restock, KicksUSA, and many small sneaker boutiques around the country. For more information about Reshoevn8r, visit reshoevn8r.com

Share article on social media or email:

LOS ANGELES (PRWEB)
May 06, 2020

Luxury bedding company Blissy, made famous by their incredible success with their silk pillowcases, has announced it’s new donation initiative. Effective immediately, Blissy will donate one silk face mask to a healthcare professional in need for every silk facemask purchased through their website.

These silk face masks are new and have been created as a response to the current pandemic and face mask requirements that many cities and states have implemented. These silk masks are made out of 100% Mulberry high quality silk.

Please note, these face masks are not intended to be FDA approved face masks to protect against all bacteria or viruses. They provide the same protection that a DIY face mask provides.

The purpose of this mask is to provide comfort and to protect the wearer’s face. Healthcare professionals can simply wear these under their medical face masks to improve comfort and reduce friction on their skin from a medical face mask during a long shift.

“At Blissy, it’s our goal to make a positive impact in as many lives as possible with our products. But during this current situation we felt like we needed to do more. Which is why we developed our own Silk Face Masks.” – Blissy CEO

Blissy Silk Face Masks can be found on the official Blissy website here – http://www.blissy.com

Share article on social media or email:

PHOENIX (PRWEB)
May 06, 2020

Halfpenny Technologies, Inc., a wholly owned subsidiary of Accumen, Inc., today announced the launch of its COVID-19 Test Capacity and Routing Network (The “Network”). The Network addresses three critical areas of need identified by hospitals and health systems throughout the current healthcare crisis: real-time availability of hospital and labs testing capacity, order entry and routing, and delivery of results to all appropriate parties. This level of connectivity in turn delivers faster turnaround times for these vitally important tests and results.

“Large-scale tracking of laboratory capacity is essential to achieving efficient turnaround times for COVID-19 testing. We are proud to be able to leverage our existing footprint of 870 hospitals and labs to play an active role combating the spread of this coronavirus,” said BG Porter, Accumen’s Chief Executive Officer.

“Halfpenny Technologies operates secure Clinical Data Exchange Networks (cloud-based hubs and portals) across 48 states. This network integrates with the most prevalent lab and hospital information systems and over 400 electronic health record (EHR) systems. As these systems manage clinical data for the majority of the U.S. population, Accumen is uniquely positioned to facilitate the rapid deployment of regional COVID-19 Network hubs to facilitate test capacity tracking, order dispatching and results routing,” added Charles Halfpenny, Chief Technology Officer at Accumen.

The Rockefeller Foundation is partnering with Accumen to address this lab data operability need. A private foundation, founded by the six-generation Rockefeller family, is focused on the well-being of humanity and advancing innovations around the world, including healthcare.

“We are working collaboratively to accelerate diagnostic testing for COVID-19 with healthcare organizations and other entities like The Rockefeller Foundation that has published its plan to beat back COVID-19 and get Americans back to work more safely. The network is designed to bring unprecedented levels of transparency to testing and results, for COVID-19 and future viruses. We are proud to work with Accumen and support hospitals across the country in their participation,” said Mike Pellini, Managing Partner of Health Venture Firm Section 32 and diagnostic expert who has been contributing to the Rockefeller plan.

Order Processing

Each regional Network hub receives COVID-19 test orders from EHR systems in local physician practices, hospitals, temporary hospitals and drive-thru testing facilities. Those orders are then routed to the closest regional lab with capacity. The orders are submitted in the required format, together with the necessary information to ensure proper laboratory billing, in advance of the specimens’ arrival.

The Network also provides a secure website for order entry to accommodate any sites that lack electronic ordering capabilities.

The Network determines which laboratory is best suited to perform the relevant test, and communicates this back to the ordering system, accompanied by labels and a requisition clearly identifying the destination lab for the ordering specimen.

Test Reporting

As COVID-19 test results are reported to the hub, the automated routing rules direct results to the ordering physicians’ EHR system, health plans, contact tracing solutions, state health departments, CDC, and other agencies as required. Results can also be retrieved from a secure website.

COVID-19 Test Capacity and Routing Network dashboards show lab capacity and turnaround times in real-time, including grouping by platform and Logistical Observation Identifiers Names and Codes (LOINC) to help address reagent and assay inventory imbalances. The Network also supplies information to a national hub for federal health agencies to use to manage the COVID-19 crisis.

Hospitals and labs that are offering COVID-19 testing and would like to join Halfpenny Technologies’ COVID-19 Test Capacity Network, should contact Dan McGuinn at (610) 574-5085. Health plans that would like to participate, should contact Wendi Beld at (970) 391-9577.

About Halfpenny Technologies

Founded in 2000, Halfpenny Technologies allows for the exchange and analysis of clinical data to improve patient care. Halfpenny Technologies is a leading provider of clinical data exchange and business intelligence solutions. Its cloud‐based, fully managed solutions provide clinicians, labs, hospitals, pharmacies, accountable care organizations (ACOs) and health plans with a secure, vendor‐neutral infrastructure that supports care coordination, care management, regulatory requirements and data analysis within and between healthcare organizations. For more information, visit http://www.halfpenny.com.

About Accumen Inc.

At Accumen, our focus is helping healthcare get better, faster. Accumen is a technology-enabled organization that partners with hospital, health system, commercial laboratory and payer clients, to provide strategic solutions and services that deliver sustainable performance improvements. Our offerings include lab and imaging transformation, consulting, supply chain optimization, lab outreach, 3D post-processing, patient blood utilization, test utilization, anemia management and clinical data exchange. Accumen’s offerings enable our clients to achieve and exceed their cost, quality, and service targets, as well as deliver excellent patient care through evidence-based data and clinical decision support capabilities. Find out more at http://www.Accumen.com.

Disclaimer: Neither Accumen nor Halfpenny has any authority, responsibility, or liability with respect to any clinical decisions made by – or in connection with – a provider’s laboratory, patient blood management, or other operations. Nothing herein and no aspect of any services provided by Accumen or Halfpenny is intended – or shall be deemed – to subordinate, usurp, or otherwise diminish any providers’ sole authority and discretion and responsibility with respect to all clinical decision-making for its patients.

Accumen Contact

Kimberly MacDowell, Chief Marketing Officer

Phone: 858.621.3167 | Email: kmacdowell@accumen.com

2111 E Highland Ave, Ste 145 | Phoenix, AZ 85016

Media Contact

Lisa Osborne, CEO

Rana Healthcare Solutions

Phone: 206.992.5245 | Email: lisa@ranahealth.com